Other Species / Isoforms
  SCML2 (human)      LTP 

LTP (Low Throughput Papers) : The number of records in which this modification site was determined using methods other than discovery mass spectrometry.

 HTP 

HTP (High Throughput Papers): The number of records in which this modification site was assigned using ONLY proteomic discovery mass spectrometry.

 
S9-p
GQTVNEDsMDVkKEN
0 2
SCML2 (human) GQTVNEDsMDVkKEN S9-p
SCML2 (mouse) GQTANEDHFDWDKYL H9
SCML2 iso2 (mouse) GQTANEDHFDWDKYL H9
SCML2 (rat) gap -
K13-sm
NEDsMDVkKENQEkt
0 2
SCML2 (human) NEDsMDVkKENQEkt K13-sm
SCML2 (mouse) gap -
SCML2 iso2 (mouse) gap -
SCML2 (rat) gap -
K19-ub
VkKENQEktPQSSTS
0 1
SCML2 (human) VkKENQEktPQSSTS K19-ub
SCML2 (mouse) gap -
SCML2 iso2 (mouse) gap -
SCML2 (rat) gap -
T20-p
kKENQEktPQSSTSS
0 1
SCML2 (human) kKENQEktPQSSTSS T20-p
SCML2 (mouse) gap -
SCML2 iso2 (mouse) gap -
SCML2 (rat) gap -
K40-ub
FHWEEYLkETGSISA
0 1
SCML2 (human) FHWEEYLkETGSISA K40-ub
SCML2 (mouse) FDWDKYLKETGSISA K17
SCML2 iso2 (mouse) FDWDKYLKETGSISA K17
SCML2 (rat) FDWDKYLKETGSVSA K11
K64-ub
IPPVNDFkVGMkLEA
0 1
SCML2 (human) IPPVNDFkVGMkLEA K64-ub
SCML2 (mouse) TPPTNEFKIGMKLEA K41
SCML2 iso2 (mouse) TPPTNEFKIGMKLEA K41
SCML2 (rat) TPPTNEFQIGMKLEA Q35
K68-ub
NDFkVGMkLEARDPR
0 1
SCML2 (human) NDFkVGMkLEARDPR K68-ub
SCML2 (mouse) NEFKIGMKLEARDPR K45
SCML2 iso2 (mouse) NEFKIGMKLEARDPR K45
SCML2 (rat) NEFQIGMKLEARDPR K39
K123-m1
QPVGTCEkEGDLLQP
Downstream
0 1
Effects on Modified Protein
  • molecular association, regulation
SCML2 (human) QPVGTCEkEGDLLQP K123-m1
SCML2 (mouse) QPVGTCEQGGDLLQP Q100
SCML2 iso2 (mouse) QPVGTCEQGGDLLQP Q100
SCML2 (rat) QPVGTCEQEGDLLQP Q94
K161-sm
MASATLFkkEPPKPP
0 2
SCML2 (human) MASATLFkkEPPKPP K161-sm
SCML2 (mouse) LAPAVFFKEEPPRPL K138
SCML2 iso2 (mouse) LASAVFFKEEPPRPL K138
SCML2 (rat) LAPAVFFKKEPPRPP K132
K162-ub
ASATLFkkEPPKPPL
0 1
SCML2 (human) ASATLFkkEPPKPPL K162-ub
SCML2 (mouse) APAVFFKEEPPRPLQ E139
SCML2 iso2 (mouse) ASAVFFKEEPPRPLQ E139
SCML2 (rat) APAVFFKKEPPRPPQ K133
K177-ub
NNFKVGMkLEAIDKk
0 1
SCML2 (human) NNFKVGMkLEAIDKk K177-ub
SCML2 (mouse) NNFIVGMKIEAVDRK K154
SCML2 iso2 (mouse) NNFIVGMKIEAVDRK K154
SCML2 (rat) NNFIVGMKIEAIDRK K148
K177-sm
NNFKVGMkLEAIDKk
0 2
SCML2 (human) NNFKVGMkLEAIDKk K177-sm
SCML2 (mouse) NNFIVGMKIEAVDRK K154
SCML2 iso2 (mouse) NNFIVGMKIEAVDRK K154
SCML2 (rat) NNFIVGMKIEAIDRK K148
K184-ub
kLEAIDKkNPYLICP
0 1
SCML2 (human) kLEAIDKkNPYLICP K184-ub
SCML2 (mouse) KIEAVDRKNPFMICP K161
SCML2 iso2 (mouse) KIEAVDRKNPFMICP K161
SCML2 (rat) KIEAIDRKNPFMICP K155
K184-sm
kLEAIDKkNPYLICP
0 1
SCML2 (human) kLEAIDKkNPYLICP K184-sm
SCML2 (mouse) KIEAVDRKNPFMICP K161
SCML2 iso2 (mouse) KIEAVDRKNPFMICP K161
SCML2 (rat) KIEAIDRKNPFMICP K155
-
gap
0 1
SCML2 (human) gap -
SCML2 (mouse) QGDAPAEkKRKGKTV K385-ub
SCML2 iso2 (mouse) QGDAPAEKKRKGKTV K384
SCML2 (rat) PDINKAEKKRRGKTV K359
-
gap
0 1
SCML2 (human) gap -
SCML2 (mouse) QGDAPAEkKRKGKTV K413-ub
SCML2 iso2 (mouse) QGDAPAEKKRKGKTV K412
SCML2 (rat) PVLNKAEKKRKGKTV K391
-
gap
0 1
SCML2 (human) gap -
SCML2 (mouse) QGDAPAEkKRKGKTV K469-ub
SCML2 iso2 (mouse) QGDAPAEKKRKGKTV K468
SCML2 (rat) PDLNKAEINRKGRTV I423
-
gap
0 1
SCML2 (human) gap -
SCML2 (mouse) QGDAPAEkKRKGKTV K497-ub
SCML2 iso2 (mouse) QGDAPAEKKRKGKTV K496
SCML2 (rat) RGAASAEKKRKGKTI K451
-
gap
0 1
SCML2 (human) gap -
SCML2 (mouse) QGDAPAEkKRKGKTV K553-ub
SCML2 iso2 (mouse) QGDAPAEKKRKGKTV K552
SCML2 (rat) SDLNKAEKNPKGRRV K515
-
gap
0 1
SCML2 (human) gap -
SCML2 (mouse) QGDAPAEkKPKGKRV K581-ub
SCML2 iso2 (mouse) QGDAPAEKKPKGKRV K580
SCML2 (rat) AAGPEPNKAEAKPKG K544
K248-ub
GTSVPIVkNIAktEs
0 1
SCML2 (human) GTSVPIVkNIAktEs K248-ub
SCML2 (mouse) AEkKPKGKRVTKSRK K586
SCML2 iso2 (mouse) AEKKPKGKRVTKSRK K585
SCML2 (rat) AEAKPKGRRVTKPRK R552
K252-sm
PIVkNIAktEssPsE
0 3
SCML2 (human) PIVkNIAktEssPsE K252-sm
SCML2 (mouse) PKGKRVTKSRKDQAQ K590
SCML2 iso2 (mouse) PKGKRVTKSRKDQAQ K589
SCML2 (rat) PKGRRVTKPRKDQDQ K556
-
gap
0 1
SCML2 (human) gap -
SCML2 (mouse) gap -
SCML2 iso2 (mouse) EAMPALFsALSVSsT S609-p
SCML2 (rat) gap -
-
gap
0 1
SCML2 (human) gap -
SCML2 (mouse) MPALSVSSTERTPPS S612
SCML2 iso2 (mouse) FsALSVSsTERtPPs S615-p
SCML2 (rat) MPALSVSSTEKTPPS S578
T253-p
IVkNIAktEssPsEA
0 2
SCML2 (human) IVkNIAktEssPsEA T253-p
SCML2 (mouse) PALSVSSTERTPPSS T613
SCML2 iso2 (mouse) sALSVSsTERtPPss T616
SCML2 (rat) PALSVSSTEKTPPSS T579
S255-p
kNIAktEssPsEAsQ
0 1
SCML2 (human) kNIAktEssPsEAsQ S255-p
SCML2 (mouse) LSVSSTERTPPSSSE R615
SCML2 iso2 (mouse) LSVSsTERtPPsssE R618
SCML2 (rat) LSVSSTEKTPPSSSE K581
S256-p
NIAktEssPsEAsQH
0 6
SCML2 (human) NIAktEssPsEAsQH S256-p
SCML2 (mouse) SVSSTERTPPSSSEQ T616
SCML2 iso2 (mouse) SVSsTERtPPsssEQ T619-p
SCML2 (rat) SVSSTEKTPPSSSEQ T582
-
gap
0 1
SCML2 (human) gap -
SCML2 (mouse) STERTPPSSSEQPKS S619
SCML2 iso2 (mouse) sTERtPPsssEQPKS S622-p
SCML2 (rat) STEKTPPSSSEQPKS S585
-
gap
0 1
SCML2 (human) gap -
SCML2 (mouse) TERTPPSSSEQPKSS S620
SCML2 iso2 (mouse) TERtPPsssEQPKSS S623-p
SCML2 (rat) TEKTPPSSSEQPKSS S586
-
gap
0 1
SCML2 (human) gap -
SCML2 (mouse) ERTPPSSSEQPKSST S621
SCML2 iso2 (mouse) ERtPPsssEQPKSST S624-p
SCML2 (rat) EKTPPSSSEQPKSST S587
-
gap
0 1
SCML2 (human) gap -
SCML2 (mouse) gap -
SCML2 iso2 (mouse) gap -
SCML2 (rat) PKSSAFGkPKSSTSK K605-ac
S258-p
AktEssPsEAsQHsM
0 3
SCML2 (human) AktEssPsEAsQHsM S258-p
SCML2 (mouse) SGKTKSTSRGAQTSR S636
SCML2 iso2 (mouse) SGKTKSTSRGAQTSR S639
SCML2 (rat) GkPKSSTSKGTQPSR S611
S261-p
EssPsEAsQHsMQsP
0 2
SCML2 (human) EssPsEAsQHsMQsP S261-p
SCML2 (mouse) TKSTSRGAQTSRKSP A639
SCML2 iso2 (mouse) TKSTSRGAQTSRKSP A642
SCML2 (rat) KSSTSKGTQPSRKSP T614
S264-p
PsEAsQHsMQsPQKT
0 4
SCML2 (human) PsEAsQHsMQsPQKT S264-p
SCML2 (mouse) TSRGAQTSRKSPRKT S642
SCML2 iso2 (mouse) TSRGAQTSRKSPRKT S645
SCML2 (rat) TSKGTQPSRKSPRKT S617
S267-p
AsQHsMQsPQKTTLI
Upstream
1 15
Kinase, in vitro:
  • CDK1 (human)
  • CDK2 (human)
Treatment
  • ischemia
  • seliciclib
SCML2 (human) AsQHsMQsPQKTTLI S267-p
SCML2 (mouse) GAQTSRKSPRKTSVV S645
SCML2 iso2 (mouse) GAQTSRKSPRKTSVV S648
SCML2 (rat) GTQPSRKSPRKTSVP S620
K296-ac
PGPTAVPkRSssVkN
0 1
SCML2 (human) PGPTAVPkRSssVkN K296-ac
SCML2 (mouse) TGNTSSPKKGITIKI K675
SCML2 iso2 (mouse) TGNTSSPKKGITIKI K678
SCML2 (rat) AGDTSASKKGITIKI K646
S299-p
TAVPkRSssVkNItP
0 8
SCML2 (human) TAVPkRSssVkNItP S299-p
SCML2 (mouse) TSSPKKGITIKIVLP I678
SCML2 iso2 (mouse) TSSPKKGITIKIVLP I681
SCML2 (rat) TSASKKGITIKIVLP I649
S300-p
AVPkRSssVkNItPR
0 7
SCML2 (human) AVPkRSssVkNItPR S300-p
SCML2 (mouse) SSPKKGITIKIVLPK T679
SCML2 iso2 (mouse) SSPKKGITIKIVLPK T682
SCML2 (rat) SASKKGITIKIVLPK T650
K302-ub
PkRSssVkNItPRKK
0 1
SCML2 (human) PkRSssVkNItPRKK K302-ub
SCML2 (mouse) PKKGITIKIVLPKKK K681
SCML2 iso2 (mouse) PKKGITIKIVLPKKK K684
SCML2 (rat) SKKGITIKIVLPKKR K652
T305-p
SssVkNItPRKKGPN
Upstream
Downstream
1 13
Effects on Biological Processes:
  • cell cycle regulation
Kinase, in vitro:
  • CDK1 (human)
  • CDK2 (human)
Putative in vivo kinases:
  • CDK1 (human)
  • CDK2 (human)
Treatment
  • seliciclib
  • siRNA
SCML2 (human) SssVkNItPRKKGPN T305-p
SCML2 (mouse) GITIKIVLPKKKGGK L684
SCML2 iso2 (mouse) GITIKIVLPKKKGGK L687
SCML2 (rat) GITIKIVLPKKRAGR L655
K318-sm
PNSGKKEkPLPVICS
0 1
SCML2 (human) PNSGKKEkPLPVICS K318-sm
SCML2 (mouse) GKSGKKEKSIPVISS K697
SCML2 iso2 (mouse) gap -
SCML2 (rat) GRNGKKEKIIPVVSS K668
T326-p
PLPVICStSAASLkS
0 2
SCML2 (human) PLPVICStSAASLkS T326-p
SCML2 (mouse) SIPVISSTSSASLST T705
SCML2 iso2 (mouse) gap -
SCML2 (rat) IIPVVSSTSSASLSS T676
K332-ub
StSAASLkSLTRDRG
0 2
SCML2 (human) StSAASLkSLTRDRG K332-ub
SCML2 (mouse) STSSASLSTLMKSSS S711
SCML2 iso2 (mouse) gap -
SCML2 (rat) STSSASLSSLMRSSS S682
Y342-p
TRDRGMLykDVASGP
0 1
SCML2 (human) TRDRGMLykDVASGP Y342-p
SCML2 (mouse) gap -
SCML2 iso2 (mouse) gap -
SCML2 (rat) gap -
K343-ub
RDRGMLykDVASGPC
0 1
SCML2 (human) RDRGMLykDVASGPC K343-ub
SCML2 (mouse) LMKSSSSNKTSAGPS N720
SCML2 iso2 (mouse) gap -
SCML2 (rat) LMRSSSSNKTPEEPS N691
K374-ub
FGPHLDPkRIQQLPD
0 1
SCML2 (human) FGPHLDPkRIQQLPD K374-ub
SCML2 (mouse) CGPFLDPQKVQQLPN Q751
SCML2 iso2 (mouse) gap -
SCML2 (rat) CGPYLDPQKVRQLPN Q722
K407-ac
VDCALETkTVFGYLK
0 1
SCML2 (human) VDCALETkTVFGYLK K407-ac
SCML2 (mouse) VNCAFQAKDVFLFLK K784
SCML2 iso2 (mouse) gap -
SCML2 (rat) VDCAIQPKDVFLFLK K755
A478
RGHTHSSAEHDkNQS
0 1
SCML2 (human) RGHTHSSAEHDkNQS A478
SCML2 (mouse) AQVPTPDtGTDQSKP T855-p
SCML2 iso2 (mouse) gap -
SCML2 (rat) THVHTSATNIDQSKP T826
K482-ac
HSSAEHDkNQSAkED
0 1
SCML2 (human) HSSAEHDkNQSAkED K482-ac
SCML2 (mouse) TPDtGTDQSKPENGE Q859
SCML2 iso2 (mouse) gap -
SCML2 (rat) TSATNIDQSKPENEE Q830
K487-sm
HDkNQSAkEDVTERQ
0 1
SCML2 (human) HDkNQSAkEDVTERQ K487-sm
SCML2 (mouse) TDQSKPENGEPKEKR N864
SCML2 iso2 (mouse) gap -
SCML2 (rat) IDQSKPENEEPKGKR N835
S495-p
EDVTERQstKRsPQQ
0 1
SCML2 (human) EDVTERQstKRsPQQ S495-p
SCML2 (mouse) GEPKEKRSLKRLSLH S872
SCML2 iso2 (mouse) gap -
SCML2 (rat) EEPKGKRSFKRLSSQ S843
T496-p
DVTERQstKRsPQQt
0 3
SCML2 (human) DVTERQstKRsPQQt T496-p
SCML2 (mouse) EPKEKRSLKRLSLHP L873
SCML2 iso2 (mouse) gap -
SCML2 (rat) EPKGKRSFKRLSSQP F844
S499-p
ERQstKRsPQQtVPy
Upstream
1 36
Treatment
  • angiotensin_2
  • ischemia
  • metformin
  • nocodazole
  • U0126
SCML2 (human) ERQstKRsPQQtVPy S499-p
SCML2 (mouse) SLKRLSLHPHRSAPV H879
SCML2 iso2 (mouse) gap -
SCML2 (rat) SFKRLSSQPQPSAPV Q850
T503-p
tKRsPQQtVPyVVPL
0 11
SCML2 (human) tKRsPQQtVPyVVPL T503-p
SCML2 (mouse) LSLHPHRSAPVSSKV S883
SCML2 iso2 (mouse) gap -
SCML2 (rat) LSSQPQPSAPVSSKV S854
Y506-p
sPQQtVPyVVPLsPK
0 4
SCML2 (human) sPQQtVPyVVPLsPK Y506-p
SCML2 (mouse) gap -
SCML2 iso2 (mouse) gap -
SCML2 (rat) gap -
S511-p
VPyVVPLsPKLPKTk
Upstream
Downstream
2 55
Effects on Biological Processes:
  • cell cycle regulation
Kinase, in vitro:
  • CDK1 (human)
  • CDK2 (human)
Putative in vivo kinases:
  • CDK1 (human)
  • CDK2 (human)
Regulatory protein:
  • CD38 (human)
Treatment
  • angiotensin_2
  • BI_4834
  • dasatinib
  • ischemia
  • metformin
  • seliciclib
  • siRNA
  • U0126
SCML2 (human) VPyVVPLsPKLPKTk S511-p
SCML2 (mouse) PHRSAPVSSKVPRKS S887
SCML2 iso2 (mouse) gap -
SCML2 (rat) PQPSAPVSSKVPRKS S858
K518-ub
sPKLPKTkEyAsEGE
0 1
SCML2 (human) sPKLPKTkEyAsEGE K518-ub
SCML2 (mouse) SSKVPRKSGQASKGN S894
SCML2 iso2 (mouse) gap -
SCML2 (rat) SSKVPRKSGRASKGK S865
Y520-p
KLPKTkEyAsEGEPL
0 2
SCML2 (human) KLPKTkEyAsEGEPL Y520-p
SCML2 (mouse) KVPRKSGQASKGN__ Q896
SCML2 iso2 (mouse) gap -
SCML2 (rat) KVPRKSGRASKGK__ R867
S522-p
PKTkEyAsEGEPLFA
0 6
SCML2 (human) PKTkEyAsEGEPLFA S522-p
SCML2 (mouse) PRKSGQASKGN____ S898
SCML2 iso2 (mouse) gap -
SCML2 (rat) PRKSGRASKGK____ S869
K536-ub
AGGSAIPkEENLSED
0 1
SCML2 (human) AGGSAIPkEENLSED K536-ub
SCML2 (mouse) gap -
SCML2 iso2 (mouse) gap -
SCML2 (rat) gap -
K536-sm
AGGSAIPkEENLSED
0 2
SCML2 (human) AGGSAIPkEENLSED K536-sm
SCML2 (mouse) gap -
SCML2 iso2 (mouse) gap -
SCML2 (rat) gap -
K545-ub
ENLSEDSkSSSLNSG
0 1
SCML2 (human) ENLSEDSkSSSLNSG K545-ub
SCML2 (mouse) gap -
SCML2 iso2 (mouse) gap -
SCML2 (rat) gap -
K545-sm
ENLSEDSkSSSLNSG
0 1
SCML2 (human) ENLSEDSkSSSLNSG K545-sm
SCML2 (mouse) gap -
SCML2 iso2 (mouse) gap -
SCML2 (rat) gap -
T567-p
RNPMYIHtsVsQDFS
0 1
SCML2 (human) RNPMYIHtsVsQDFS T567-p
SCML2 (mouse) gap -
SCML2 iso2 (mouse) gap -
SCML2 (rat) gap -
S568-p
NPMYIHtsVsQDFSR
0 1
SCML2 (human) NPMYIHtsVsQDFSR S568-p
SCML2 (mouse) gap -
SCML2 iso2 (mouse) gap -
SCML2 (rat) gap -
S570-p
MYIHtsVsQDFSRsV
Upstream
Downstream
1 16
Effects on Modified Protein
  • molecular association, regulation
  • protein stabilization
Putative in vivo kinases:
  • Chk1 (human)
Treatment
  • AZD6738
  • AZD7762
  • camptothecin
  • ionizing_radiation
  • KU-55933
  • NU7026
  • prexasertib
  • UV
SCML2 (human) MYIHtsVsQDFSRsV S570-p
SCML2 (mouse) gap -
SCML2 iso2 (mouse) gap -
SCML2 (rat) gap -
S576-p
VsQDFSRsVPGTTss
0 2
SCML2 (human) VsQDFSRsVPGTTss S576-p
SCML2 (mouse) gap -
SCML2 iso2 (mouse) gap -
SCML2 (rat) gap -
S582-p
RsVPGTTssPLVGDI
0 1
SCML2 (human) RsVPGTTssPLVGDI S582-p
SCML2 (mouse) gap -
SCML2 iso2 (mouse) gap -
SCML2 (rat) gap -
S583-p
sVPGTTssPLVGDIs
0 7
SCML2 (human) sVPGTTssPLVGDIs S583-p
SCML2 (mouse) gap -
SCML2 iso2 (mouse) gap -
SCML2 (rat) gap -
S590-p
sPLVGDIsPKssPHE
Upstream
Downstream
1 34
Effects on Biological Processes:
  • cell cycle regulation
Kinase, in vitro:
  • CDK1 (human)
Putative in vivo kinases:
  • CDK1 (human)
  • CDK2 (human)
Treatment
  • BI2536
  • dasatinib
  • ischemia
  • nocodazole
  • seliciclib
  • siRNA
SCML2 (human) sPLVGDIsPKssPHE S590-p
SCML2 (mouse) gap -
SCML2 iso2 (mouse) gap -
SCML2 (rat) gap -
S593-p
VGDIsPKssPHEVkF
0 2
SCML2 (human) VGDIsPKssPHEVkF S593-p
SCML2 (mouse) gap -
SCML2 iso2 (mouse) gap -
SCML2 (rat) gap -
S594-p
GDIsPKssPHEVkFQ
Upstream
0 5
Treatment
  • nocodazole
SCML2 (human) GDIsPKssPHEVkFQ S594-p
SCML2 (mouse) gap -
SCML2 iso2 (mouse) gap -
SCML2 (rat) gap -
K599-ub
KssPHEVkFQMQRks
0 2
SCML2 (human) KssPHEVkFQMQRks K599-ub
SCML2 (mouse) gap -
SCML2 iso2 (mouse) gap -
SCML2 (rat) gap -
K599-sm
KssPHEVkFQMQRks
0 1
SCML2 (human) KssPHEVkFQMQRks K599-sm
SCML2 (mouse) gap -
SCML2 iso2 (mouse) gap -
SCML2 (rat) gap -
K605-ub
VkFQMQRksEAPSYI
0 1
SCML2 (human) VkFQMQRksEAPSYI K605-ub
SCML2 (mouse) gap -
SCML2 iso2 (mouse) gap -
SCML2 (rat) gap -
K605-sm
VkFQMQRksEAPSYI
0 1
SCML2 (human) VkFQMQRksEAPSYI K605-sm
SCML2 (mouse) gap -
SCML2 iso2 (mouse) gap -
SCML2 (rat) gap -
S606-p
kFQMQRksEAPSYIA
0 6
SCML2 (human) kFQMQRksEAPSYIA S606-p
SCML2 (mouse) gap -
SCML2 iso2 (mouse) gap -
SCML2 (rat) gap -
K621-ub
VPDPSVLkQGFSKDP
0 1
SCML2 (human) VPDPSVLkQGFSKDP K621-ub
SCML2 (mouse) gap -
SCML2 iso2 (mouse) gap -
SCML2 (rat) gap -
K621-sm
VPDPSVLkQGFSKDP
0 1
SCML2 (human) VPDPSVLkQGFSKDP K621-sm
SCML2 (mouse) gap -
SCML2 iso2 (mouse) gap -
SCML2 (rat) gap -
K663-ub
RQHEIDGkALFLLKs
0 1
SCML2 (human) RQHEIDGkALFLLKs K663-ub
SCML2 (mouse) gap -
SCML2 iso2 (mouse) gap -
SCML2 (rat) gap -
S670-p
kALFLLKsDVMMKYM
0 1
SCML2 (human) kALFLLKsDVMMKYM S670-p
SCML2 (mouse) gap -
SCML2 iso2 (mouse) gap -
SCML2 (rat) gap -